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Biotechnology and the future of agriculture 
in Zimbabwe: strategic issues
Idah Sithole-Niang
Biotechnology is a collection of scientific disciplines that integrate natural, life 
and engineering sciences. The broad definition of biotechnology is simply the 
industrial use of living organisms or parts of living organisms to produce food, 
drugs or other products. Traditional biotechnology includes fermentation and 
the use of tissue culture in plant and animal breeding. Fermentation is used in 
the processes of making bread, beer, wine and cheese. Plant breeding employs 
vegetative, micro-propagation and tissue culture, while animal breeding uses 
techniques such as artificial insemination, super-ovulation and embryo trans­
fer. Modem biotechnology permits the transfer of genes among species regard­
less of origin, resulting in an organism with an entirely new combination of 
properties (Marvier, 2001). Other definitions of modem biotechnology include 
specific techniques such as marker-assisted selection used in both animal and 
plant breeding.
Traditional biotechnology has existed in Zimbabwe since the early 1970s 
but modem biotechnology (molecular biology, genetic engineering or gene 
modification) has only been in practice in the last decade. In the context of 
increasing human population, agricultural researchers have to develop new tech­
nologies that will help achieve increased agricultural productivity. Agricultural 
biotechnology could be of benefit to a broad range of large-scale commercial 
and smallholder farmers. There are examples from developing countries of suc­
cessful adoption of biotechnology by smallholder farmers (Gregory, Stewart 
and Starvrou, 2002; Kirsten and Gouse, 2003). This chapter focuses on the role 
of biotechnology in the agricultural sector in Zimbabwe.
Global and African overview
Development of genetic engineering technology has made significant progress 
in crop production but some countries have responded negatively to its use. 
Principal concerns relate to the safety of genetically modified crops for people 
and the environment, and conflict with other production systems (for example, 
organic systems, through gene transfer from adjacent genetically modified crops) 
and commercial systems. The tendency of genetically modified production to
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place ownership of the means of food production in the hands of a few multina­
tionals is controversial. There is considerable sentiment against the technology 
arising from the fact that it locks people's livelihoods in with profit-making 
multinational and global corporations. Multinational companies have merged 
to become huge conglomerates that threaten the seed sector throughout the 
world. Genetically modified crops fall within the discourse on globalization 
which some developing nations view as a new form of imperialism or coloni­
zation. The issue of globalization seems to have little to do with the new tech­
nology although this has become the perfect conduit for anti-genetically modi­
fied organism sentiments. The conflicts between developed and developing 
countries on the value of genetically modified crops to society have focused on 
the perceived difference in production and the food security problems that con­
stantly lace developing nations. Therefore, genetically modified crops are seen 
as the perfect answer to such food security challenges. The fact that food pro­
duced using this method from the United States of America dominates world 
food relief gives credence to the view that genetically modified crops may 
offer better alternatives to conventional food production.
Global overview
Globally, the area planted to genetically modified crops exceeded 81 million 
hectares in 2004 (James, 2004). The leading countries in terms of area planted 
were the United States of America, Argentina, Canada, Brazil, China, Para­
guay, India and South Africa. In the United States of America, there is a favour­
able regulatory environment that has allowed genetically modified crops to 
move quickly into the field. On the other hand, European countries are still 
engaged in debates on the use of the new technology. Public acceptance and 
the need to label foods derived from genetically modified crops continue to be 
controversial issues across the globe. The shift from input traits to output traits 
is expected to be more pronounced, with farmers realizing an increased value 
for their crops. The requirement to test genetically modified crops before re­
lease is being institutionalized in order to safeguard human health, animal health 
and the environment.
Genetically modified crops in developed countries include those express­
ing tolerance to herbicides such as glyphosate, insect tolerance using toxic pro­
teins derived from a soil bacterium, Bacillus thuringiensis, in maize and cot­
ton, and virus resistance in papaya, squash and tomatoes. There are examples 
of crops with resistance to bacterial and fungal pathogens as well. Golden rice 
represents a different class of these engineered crops in that pro-vitamin A is an 
output trait. Experimentation by various research institutes continues on vari­
ous types of genetically modified crops as nutritional genomics (Della Penna, 
1999). Furthermore these new products will be beneficial to consumers, farm­
ers and the industry.
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AAT Sheep AAT = alpha 1-antitrypsin, inherited 
deficiency leads to emphysema
15,000
tPA Goat TPA = Tissue plasminogen activator, 
treatment for blood clots
75,000
Factor VIII Sheep Factors VII, IX = blood clotting factors, 
treatment for haemophilia
37,000
Factor IX Sheep 20.000
Haemo­
globin
Pig Haemoglobin = blood substitute for human 
transfusion
3,000
Lactofcrrin Cow Lactofcrrin = infant formula additive 20.000
CFTR Sheep,
mouse
CFTR = Cystic fibrosis transmembrane 




Pig Human protein C = anti-coagulant, 
treatment for blood clots
1.000.000
Source: Betsch and Webber (1995)
The transgenic animals industry has led in the cloning of genetically modified 
pigs where a gene responsible for transplant rejection has been deleted. PPL 
Therapeutics, the company that was created to commercialize the cloning tech­
niques developed at the Roslin Institute in Scotland, is one of two companies 
that successfully cloned the pigs. It is envisaged that in future other transgenic 
pigs will be created as research on xeno-transplants takes centre stage. A list of 
some transgenic animals currently on the market is provided in table 29.1.
While research has been done in genetic engineering of plants and animals 
to produce genetically modified organisms in developed countries, some inde­
pendent scientists, respecting the precautionary principle, recommend that wide­
spread use should be restricted. An independent panel on genetically modified 
crops said:
‘Genetically modified crops have failed to deliver the promised benefits and 
are posing escalating problems on farms. Transgenic contamination is now
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widely acknowledged to be unavoidable and hence there can be no co-exist­
ence of genetically modified and non-genetically modified agriculture. Most 
important of all, genetically modified crops have not been proved safe. On 
the contrary, sufficient evidence has emerged to raise safety concerns that, if 
ignored, could result in irreversible damage to health and the environment. 
Genetically modified crops should therefore be firmly rejected now.'
Although countries could be covered by a new legally-binding treaty that came 
into force on 11 September 2003, the United States of America did not sign this 
Biosafety Protocol.
African overview
While data on research capacity is lacking in some African countries, the pres­
ence of a biosafety regulatory framework within countries is often a fairly good 
indicator of the level of biotechnology activities. Due to the lack of human 
resources. African governments generally do not invest in this area until a product 
comes in from outside, as was the case for Zambia with the introduction of 
transgenic cotton and Egypt when it sought collaboration with the United States 
Agency for International Development under the agricultural biotechnology 
support programme. Part of this effort has helped Egypt put five transgenic 
crops (tomato, maize, cotton, squash and potato) in the field for socio-eco­
nomic impact assessment (Brenner, 2004).
The backlash in Europe against genetically modified crops has certainly 
not helped many African countries, as Europe is their major trading partner. 
The African Agency for Biotechnology in Algeria has established biotechnol­
ogy networks. Furthermore, research activities have increased in West Africa 
on various options in the use of genetic modification (Alhanson, 2003). Some 
countries, such as Senegal, have commenced research on biological nitrogen 
fixation technology and used tissue culture for the micro-propagation of indig­
enous tree species. The Cote d'Ivoire has done research on tuber crops such as 
cassava and yam. In Nigeria the government has established a biotechnology 
agency to streamline biotechnology activities in the country in view of the 
controversies that face the industry. The University of Nigeria has the African 
Biosciences Network dealing with the genetic improvement of crops, farm ani­
mals and disease control using new vaccines. The major aim of the network is 
to increase African capacity to research on genetic modification rather than to 
accept research results from the north.
In East Africa, both Kenya and Uganda have regulatory frameworks in 
place. The two countries have highly developed traditional biotechnology sec­
tors for both crops and livestock. Kenya in 2003/04 commenced field-testing 
transgenic virus-resistant sweet potato and developed transgenic maize that is 
insecticidal to stem borer (Wafula, Cohen and Wanyangu, 2004). This work
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was carried out in collaboration with the International Maize and Wheat Im­
provement Centre in Mexico. A maize project funded by the Dutch govern­
ment used marker-assisted breeding to confer drought tolerance and insect re­
sistance. Other projects involved development of recombinant vaccines against 
caprine pox and rinderpest, embryo transfer and disease diagnostics (Mugabe, 
Kameri-Mbote and Odame, 2000). The Uganda government agreed to fund 
transgenic research for five years on black sigatoka disease, weevil and nema­
tode resistance in bananas (DeVries and Toenniessen, 2002). Ethiopia was in­
volved in the micro-propagation of forest trees, tissue culture on tef and carried 
out research on biofertilizers and nitrogen fixation. The livestock industry in 
Ethiopia conducted some experimentation on vaccine development and dis­
ease diagnosis.
In Tanzania, the use of tissue culture for mass propagation and provision of 
disease-free planting materials for bananas, cashew nut and sweet potato is 
prevalent. Neither Tanzania nor Ethiopia have regulatory frameworks in place 
but these are being developed through collaborative research with the Swed­
ish-funded Bio-EARN project that is involved in building capacity in both bio­
technology and biosafety.
Southern Africa
In southern Africa, South Africa took leadership in agricultural biotechnology 
research followed by Zimbabwe and to a limited extent by Namibia, Zambia 
and Malawi. In South Africa, agricultural biotechnology activities began in the 
mid-1970s when plant tissue culture techniques were used, while genetic modi­
fication was introduced a decade later. The agricultural biotechnology sector is 
the second largest after the medical and pharmaceutical sector. South Africa 
has high research capacity because of large investments in technical and finan­
cial teams due to infrastructural resource capacity. There are well over 500 
biotechnology projects underway in South Africa. This investment is targeted 
for markets in sub-Saharan Africa and other trading regions. Such an approach 
has the added advantage of ensuring that the quality of product developed will 
be of export quality. Concurrent with this development in South Africa is the 
growth in other business sectors such as information technology, telecommu­
nication and banking. South Africa has also offered opportunities for students 
to train in biotechnology and the training offered is cost effective and of a high 
standard. South Africa has conducted well over 350 field tests and commer­
cialized four transgenic products. It represents the first country in the world to 
carry out a socio-economic impact assessment for a transgenic crop grown by 
small-scale farmers (Ismael, Bennett and Morse, 2001). South Africa has hosted 
a number of training initiatives in biosafety and public awareness.
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Application of biotechnology in Zimbabwe
Crops
Tissue culture is being used in Zimbabwe for the transformation of cassava 
(Manihot esculanta), tobacco, maize and the provision of pathogen-free plant­
ing material for sweet potato (Ipomoea batatas). The provision of pathogen- 
free sweet potato planting materials is an ongoing activity at the Biotechnol­
ogy Research Institute in collaboration with the Tobacco Research Board using 
funding from the Biotechnology Trust of Zimbabwe. The legume inoculanl 
factory at the Grasslands Research Station in Marondera produces rhizobium 
inoculants. This facility was used largely by commercial farmers in the past but 
smallholder farmers also benefited from its work. This initiative by the Bio­
technology Trust of Zimbabwe in collaboration with the University of Zimba­
bwe's Department of Soil Sciences was aimed at improving smallholder crop 
production. The Horticultural Research Institute, also located at Marondera. is 
involved in tissue culture of vegetable and ornamental crops such as sweet 
potato and cut flowers, while private companies, such as Blucdale Enterprises, 
use the tissue culture technology to generate disease-free planting materials for 
Irish potato, sweet potato, banana, strawberry and roses.
The Biotechnology Research Institute, in collaboration with the Interna­
tional Maize and Wheat Improvement Centre, has been developing both in­
sect-resistant and drought-tolerant maize using marker-assisted selection. The 
University of Zimbabwe’s Department of Crop Science also identified markers 
that are linked to the Striga asiatica resistant trait in sorghum. The Department 
of Biochemistry and the Institute of Food, Nutrition and Family Science have 
done research on fermentation in the use of sorghum and indigenous fruits in 
the preparation of weaning foods and traditional beverages. They character­
ized micro-organisms for use as starter cultures in the fermentation of milk at 
the village level. The Department of Biochemistry is involved in isolating lipases, 
melanin and lectins from indigenous trees for use in industry and diagnostics. 
Research work is also ongoing on the treatment of industrial effluent. The ge­
netic improvement of cowpea to confer both virus and herbicide tolerance has 
been done including the molecular characterization of the flavonoid pathway 
in sorghum in order to improve its milling qualities and usefulness as livestock 
feed.
The Department of Applied Biology and Biochemistry at the National 
University of Science and Technology in Bulawayo has conducted research on 
lipases, lectins and indigenous fungi. The Agronomy Institute in the Depart­
ment of Agricultural Research and Extension has used biological pests to con­
trol the water hyacinth in Lake Chivero. All in all, several institutions are ac­
tive in biotechnology research in Zimbabwe (Sithole-Niang and Mugwagwa, 
2000; Sithole-Niang. 2001).
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Livestock
Traditional biotechnology has had a noticeable impact on Zimbabwe’s agricul­
ture, not only on crops but in the livestock sector as well. Biotechnology is 
used in the dairy industry to manufacture local cheeses and in breeding through 
the use of artificial insemination, embryo transfers, embryo cryopreservation 
and in-vitro embryo production to develop both elite and indigenous breeds. 
The early cases of using biotechnology in the livestock industry in Zimbabwe 
date back to 1909 when attenuated vaccines were first made locally. Since 2000 
biotechnology has been used in the culture of animal pathogens and the pro­
duction of recombinant antigens for diagnostics. The Biotechnology Trust of 
Zimbabwe funded two projects on livestock improvement: one on molecular 
diagnostics of cattle reproductive diseases where farmers were taught how to 
recognize disease symptoms at the point of care, and the other on livestock 
feeding strategies, silage making and forage production. The project on disease 
diagnosis and detection was collaborative with small-scale farmers in Hwedza 
and Buhera districts and the Central Veterinary Laboratory. Research on nutri­
tion was carried out in collaboration with scientists at the Grasslands Research 
Station and at Africa University.
Biopharming is the largest growing sector in biotechnology product devel­
opment. Pharming is the production of human pharmaceuticals in transgenic 
animals. The technology dates back to 1982 when the first transgenic mouse 
was made. This produced the tissue plasminogen activator (tPA). The use of 
recombinant products such as recombinant bovine growth hormone (also known 
as bovine somatotropin -  bST) sparked controversy with dairy farmers in the 
mid-western states of the United States of America. However, on the contrary, 
the use of pharmaceuticals produced as recombinant proteins did not attract 
much controversy. In Zimbabwe, research was conducted in the early 1990s at 
Henderson Research Station to test the efficacy of the recombinant hormone 
on indigenous breeds (Phipps, Madakadze, Mutsvangwa, Hard and de Kerchove. 
1991). Milk yields were increased from 226kg for the control animals to 993kg 
for the treated cows. The recombinant bovine somatotropin did not only in­
crease the milk yields but it also prolonged the period of lactation in indig­
enous Mashona cattle. This could be a breakthrough because the breed is well 
known for its low milk yields and short lactation periods. Clearly, from the 
Zimbabwean perspective, it would be more beneficial to extend these trials to 
small-scale farmers and also ensure that an efficient and workable marketing 
system is in place to absorb the increased milk yields. However, there is need 
to carry out thorough assessment through participatory research to establish 




Zimbabwe’s forests and woodlands are being deforested at an alarming rate 
with estimates as high as 100,000 hectares per year being cited in the Science 
and technology policy document. Pines and eucalyptus are grown on commer­
cial plantations and grow faster, yet the exotic trees have the drawback of using 
a lot of underground water and are not durable in tropical climates. On the 
other hand, indigenous hardwoods like mukwa and mahogany have long matu­
ration times. Although a range of biotechnological tools are now widely avail­
able, very few of these have been applied to forestry improvement. Limited 
funding and a lack of capacity in both human resources and infrastructure are 
often cited as major constraints to biotechnology development in the forestry 
sector. The size of the industry in Zimbabwe is rather limited, while pressure 
from environmentalists opposed to genetic modification is already mounting 
and gaining ground. This resistance is threatening to hinder forestry certifica­
tion, leaving researchers in a dilemma as to whether genetic modification in 
particular could be used to improve forestry products in Zimbabwe. However, 
macro-propagation and micro-propagation have played a major role in the main­
tenance of both plantation and some indigenous tree species. The use of mo­
lecular deoxyribonucleic acid (DNA) markers could aid in a wide variety of 
applications, such as in selection, crossing and identification. Technology for 
conferring resistance against termites could improve forest production.
Fisheries
Zimbabwe has 114 indigenous fish species and 30 exotic species that have 
been introduced over time. The largest fishery is at Lake Kariba. The country 
produces about 25,000 tonnes of fish per year and less than a thousand tonnes 
is exported. Aquaculture is also present on a limited scale, with commercial 
fish farming occurring in tanks and ponds to produce trout, bream, carp and 
prawns. Most of the research effort has been devoted to fish nutrition, disease 
control, fish recruitment and fish ecology. There are seven research stations 
that have been established in the country and these fall under the Ministry of 
Environment and Tourism, although some of the research on aquaculture of 
tilapia is also ongoing at Henderson Research Station which falls under the 
Ministry of Agriculture and Rural Development. Future research needs have 
been identified in the areas of pathology, species selection and pond ecology. 
These are areas that could be addressed using biotechnological tools such as 
marker-assisted selection, the use of molecular markers to study genetic diver­
sity and species identification. A preliminary genetic diversity study has been 
initiated at the University of Zimbabwe’s departments of Biological Sciences 
and Biochemistry in collaboration with Bindura University. The country could 
explore the possibility of disseminating aquaculture much more widely and 
also needs to develop bioremediation strategies in order to address pollution in 
water bodies.
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Vaccines
The latest innovation in vaccine production has been the production of DNA 
vaccines in animals as well as the production of plant-based vaccines (Daniell, 
Streatfield and Wycoff, 2001; Peterson and Amtzen, 2004). With DNA vaccines 
the construct is transiently expressed and is finally cleared from the system 
after 18 months. This might mean that the animal could not be slaughtered 
before the window time has lapsed. Normally this kind of vaccine is given 
intramuscularly then the antigen presenting cells deliver it to the immune sys­
tem, which then allows it to go systemic. The scientists at Heartwater Project 
are developing a DNA vaccine for Cowdria ruminantium.
Plant-based vaccines use the concept that the first line of defence is the gut 
mucosa and the genito-urinary tract (Peterson and Amtzen, 2004). The tech­
nology takes advantage of the fact that proteins can be expressed in plants in an 
immunogenic form and can be processed post-translationally to their final func­
tional forms if necessary. The antigens can be expressed in edible parts of plants 
such as bananas, carrots and tomatoes and can be taken raw by children. They 
can be grown in the tropics and be made available at the point of source with­
out the production and preservation costs associated with vaccines currently 
available or the safety concerns associated with vaccines derived from tissue 
culture. However the issue of the exact dose to take and the development of 
oral tolerance require further research. It is interesting to note that engerex the 




Biosafety refers to the safe management of modem biotechnology and respon­
sible deployment of genetic modification processes in order to safeguard bio­
logical diversity, local livelihoods, humanity and the environment in general. 
This is also aimed at making genetic modification research compliant with 
local conditions as experimentation results differ depending on climatic re­
gimes. Efforts to come up with a biosafety legal framework in Zimbabwe dates 
back to the early 1990s when it was recognized that a biosafety board could not 
be fully constituted without it being governed by an existing piece of legisla­
tion. The Research Act was amended in 1998 to include biotechnological as­
pects of research and use. Furthermore, a fully fledged Ministry of Science and 
Technology was established in 2005. The ministry is located in the Office of 
the President and the Cabinet with a mandate to develop the regulatory frame­
work for biotechnology. Zimbabwe now has an explicit policy on biosafety 
(Sithole-Niang and Mugwagwa, 2000) and regulations have been gazetted
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(Statutory Instrument 20/2000). A biosafety board has been set up and guide­
lines have been prepared to guide researchers in their various institutions. The 
Science and technology policy document has been published and contains the 
policy on biotechnology that highlights the need to engage in biotechnology 
research and development to increase Zimbabwe’s capacity and capability. The 
document emphasizes the sovereign right of the public to be safeguarded from 
the deleterious effects of the science, to be informed and consulted where nec­
essary, and to engage in dialogue on issues of ethical, social and religious con­
cern. Zimbabwe also reviews the regulatory framework to bring it in line with 
the requirements of the Cartagena Protocol on Biosafety.
Food safety
‘Food safety is the assurance that a food will not cause harm when it is pre­
pared or eaten according to its intended use' (Liu and Hong, 2002). The Food 
and Agriculture Organization and the World Health Organization have adopted 
the concept of substantial equivalents as being the most appropriate and practi­
cal way to evaluate food safety in food and food ingredients derived from ge­
netically modified organisms (FAO, 2004). This concept states that when a 
new food or food ingredient is substantially equivalent to an existing food, then 
that product can be treated in the same manner as other conventional foods in 
terms of safety. For genetically modified food and genetically modified de­
rived food ingredients, therefore, it will be the product that is tested for safety 
rather than the process that was used to create it. It therefore means that these 
new foods (in terms of food safety) are going to be subjected to the same evalu­
ations as those applied to foods derived from conventionally bred materials.
Environmental risks
There are multiple risks associated with genetic engineering on the environ­
ment. Among the known risks are the following:
• Herbicide resistance to weeds producing ‘super-weeds' which require more 
environmentally toxic countermeasures and incur higher costs to farmers;
• Insect resistance to the Bt pesticides due to plants which express Bt toxins 
constantly;
• Herbicide resistant crops tend to lower yields and incur higher costs as 
well as increase use of herbicides with high toxicity content. Acute illness 
in farmworkers may lead to chronic conditions. In addition, high dosages 
of herbicides affect biodiversity (plants and insects) in a negative way.
Some of the environmental risks resulting from the use of genetic modification 
include:
• Increased invasiveness and persistence of the transgene in the environment 
as a result of monoculturing of genetically modified crops;
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• Development of resistance in insect populations;
• Gene flow to wild relatives (out-crossing); and
• The effect on non-target organisms (Traynor and Westwood, 1999).
A number of emerging technologies are now being developed to address some 
of these safety concerns (Daniell, 1999; Smith et al.. 2000).
Intellectual property rights
Intellectual property is a collection of ideas and thoughts that are intangible 
until expressed in a tangible form so as to be protected from unauthorized use 
by someone else. Intellectual property rights are usually protected by three 
legal instruments, namely, patents, copyrights and trademarks. They afford the 
owner legal protection from unfair competition, they reward ingenuity, ensure 
the free flow of ideas and allow the owner to continue to improve and innovate 
on the creation or invention. This protection is limited in time and scope de­
pending on the country and gives the inventor the right to ownership. In recent 
years intellectual property rights have assumed worldwide importance to the 
extent that countries have had to sign treaties and agreements in order to pro­
tect their intellectual property rights and have established organizations to over­
see their application (Erbisch and Velazquez, 1998). Examples of agreements 
signed and organizations set up include the General Agreement on Trade and 
Tariffs (GATT), Trade-Related Aspects of Intellectual Property Rights (TRIPs), 
the World Intellectual Property Organization (W1PO) and the World Trade Or­
ganization (WTO).
Genetically modified crops contain patented genes and are therefore pro­
tected by patent law. This means that their use is controlled by private patent 
holders, usually the biotechnology corporations, and farmers have to pay roy­
alties or face legal action. Contamination of crops by genetically modified pol­
len from patented plants transfers ownership of the plants to the patent holder. 
This infringes farmers' rights to grow, re-use and sell seeds produced on the 
farm as enshrined in the new International Treaty on Plant Genetic Resources 
for Food and Agriculture. Their rights and free flow of agricultural seeds and 
genetic resources essential for food production are undermined by intellectual 
property rights that restrict access.
The need to protect intellectual property, genetic resources and indigenous 
knowledge in Zimbabwe has been recognized and guidelines have been put 
forward for developing national policies and legislation (Chitsike, 2000; Hulman 
and Tawonezvi, 2001). A key requirement is to assess the extent to which bio­
technology approaches to agricultural problems have penetrated traditional or 
conventional research and how this impacts on the smallholder farmer.
Other policy issues that need to be considered in the development and use of 
biotechnology in Zimbabwe include the following:
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• Public and private sector roles and partnerships;
• Socio-economic concerns such as dealing in terminator technologies that 
could lead to the inability of farmers to save or replant seed;
• Monitoring and regulating the traffic of genetically modified organisms as 
a means of ensuring adherence to safety standards;
• Labelling of genetically-modified derived food and ingredients to allow 
for personal food choice. The Codex Alimentarius Commission is currently 
working on international guidelines for labelling genetically modified foods 
and food ingredients. These guidelines would enable Zimbabwe to develop 
its own country-specific guidelines and that process is already underway; 
and
• Animal genetic conservation especially of the indigenous breeds that thrive 
in tropical Zimbabwe.
Future of biotechnology in Zimbabwe
The basic policy and legislation on biotechnology is now in place, although 
further refinements will be necessary. However, policy makers need to be aware 
of the advantages and potential risks biotechnology could introduce into agri­
cultural productivity. Consequently, any decisions that they make must recog­
nize the contribution that biotechnology is likely to make to the country.
Genomics
One of the key biotechnology areas for the future is genomics. This technology 
is driving the design and development of new crop varieties with improved 
growth, pest-resistance properties and superior nutritional characteristics. It is 
expanding our knowledge of human, plant and livestock genomes to the extent 
that new genes have become available that could not have been isolated before. 
This technology, together with bioinformatics and the use of microarrays, is 
expected to speed up the development of new crop varieties, livestock and 
diagnostic and detection procedures (Somerville and Somerville, 1999). Be­
cause of the high cost and infrastructure required for these new technologies, 
Zimbabwean scientists would benefit from collaboration with scientists in ad­
vanced laboratories elsewhere. The Biosciences Eastern and Central Africa Cen­
tre has already been launched under the NEPAD biosciences initiative.
Metabolic engineering (metabolomics)
Another area for the future is metabolic engineering which involves the use of 
recombinant DNA technology to enhance the activities of a cell by manipulat­
ing its metabolic pathways. The goal of metabolic engineering in plants is to 
produce transgenic crops in which the range, scope or nature of a plant’s exist­
ing natural products is modified to provide economically important attributes
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(Taylor, 1998). To fully exploit this technology, scientists in Zimbabwe will 
need to develop an improved understanding of cell metabolism and its com­
plexity.
Strategic issues for Zimbabwe
While traditional biotechnology has made inroads into the Zimbabwean agri­
cultural sector, modern biotechnology is still in its infancy (Sithole-Niang and 
Mug wag wa, 2000), yet the potential benefit from such technology requires 
further investigation. The problems are numerous due to lack of both financial 
and human resources -  there is a shortage of trained personnel in the area of 
agricultural biotechnology. While capacity had been achieved in previous years, 
it has subsequently been lost as many trained personnel have left the country 
due to the poor economic environment. Internal movement of staff is equally 
disruptive and means that many projects are not carried to completion. The 
shortage of suitable personnel could be addressed by government and the pri­
vate sector which must continually support training and employment creation 
in this rapidly and vastly expanding field of science. It must be recognized that 
biotechnology is a multifaceted science and after initial training, the scientists 
will continue to need further training or refresher courses in advanced labora­
tories, locally and internationally. Broad sectoral investment in human resources 
by building and retaining the critical mass is a key requirement. A vibrant bio­
technology industry could absorb some of the graduates coming out of the 
local institutions of higher learning but Zimbabwe needs to ensure that trained 
professionals are remunerated adequately.
Key individuals with expertise in certain areas, such as policy, need to be 
engaged to craft relevant biotechnology policies based on emerging global stand­
ards. In the absence of such policies, certain technological developments will 
escape Zimbabwe. Zimbabwe is also a signatory to various international trea­
ties and agreements such as the Convention on Biodiversity Conservation and 
so will need to comply with the requirements. For those issues that are still 
open to negotiation. Zimbabwe should ensure that it registers its opinion.
There is need for a concerted effort hy government and local industry to 
invest in biotechnology, as is the case in South Africa where there is the politi­
cal will for biotechnology research and development. In this regard, state sup­
port with tax relief for entrepreneurs who invest in science and technology is 
part of the long-term strategy. Additional funding mechanisms for research 
must be sought from both local and foreign investors. The development of 
research parks at national universities should be viewed as a possible avenue to 
product development. In addition, scientists are required to play a leading role 
in business and marketing. Multinational companies should be involved through 
investments in biotechnology research and development, not just through prod­
uct development and marketing.
Utah Sithole-Niung
Conclusion
The benefits from agricultural biotechnology for Zimbabwe cannot be over­
emphasized. A clear biotechnology policy on how best to move forward and 
target products that could give it a competitive advantage globally is required. 
The current Science and technology policy document falls short of that. Public 
awareness campaigns based on accurate information and an open and honest 
debate are needed. Decisions on the future of genetically modified organisms 
should be science-based. Scientists should take a proactive role in disseminat­
ing information in simple terms that the ordinary farmer can understand, other­
wise continued ignorance on the subject will remain the greatest threat to bio­
technology development in Zimbabwe.
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